Molecular Instruments and Visiopharm Announce Strategic Partnership to Combine AI-Driven Precision Pathology with HCR™ Pro Assays to Advance Clinical-Grade RNA-ISH
LOS ANGELES, Nov. 6, 2024 /PRNewswire/ -- Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, is pleased to announce...